VivoSeq
Other

Microbial Colonization

2

Pipeline Programs↗

1

Active Trials↗

2

Companies Involved↗

Microbial Colonization is an early-stage landscape with 2 programs across 2 companies. The most active players are Jakob Stokholm, Eli Lilly.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

J

Jakob Stokholm

1 program

Phase 1Eli Lilly logo

Eli Lilly

1 program

Phase 1

Pipeline

Programs by Phase

Preclinical
No programs
Phase 12

Microbiome Restoration - FMT

Professor Klaus Bønnelykke

Microbiome Restoration - FVT

Jakob Stokholm

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

4

clinical trials

Completed3 · 75%
Recruiting1 · 25%

Clinical Trials

Trial Activity

Comparison of Oral Care Solutions on Oral Microbial Colonization in Neurosurgical ICU Patients
Completed·HHarran University·N/A·NCT07365956·90 enrolled
Microbial Colonization and Change of Chronic Keratinized Hand Eczema After Using Halometasone Triclosan
Completed·—·Phase 4·NCT03246776·80 enrolled
Sport and Health a Pilot Study: Impact of Endurance Physical Activity on the Microbiological Homeostasis of the Oral Cavity of Young Adults
Completed·CCentre Hospitalier Universitaire de Nice·Preclinical·NCT05765422·103 enrolled
"Restoration of the Gut Microbiome After Cesarean Section (RestoreGut)" - A Double-blinded Randomized Placebo-controlled Trial
Recruiting·—·Phase 1·NCT06264219·80 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)